Hypercholesterolaemia clinical trials

Explore recruiting hypercholesterolaemia clinical trials.

Recruiting hypercholesterolaemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hypercholesterolaemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A clinical trial of MK-3214 taken with different liquids in healthy participants (MK-3214-002)

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

A clinical study of MK-3214 in healthy people (MK-3214-001)

Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Reassessment of statin-associated musscle symptoms in adults with familial hypercholesterolemia: A phase IV randomized double-blinded n-of-1 crossover trial including periods with atorvastatin, placebo and no study treatment

Norway

Therapeutic use (Phase IV) EU CTIS Study details

Pragmatic clinical trial to assess the utility of SLCO1B1, ABCG2, and CYP2C9 preepmtive genotyping and pharmacogenetics training on the incidence of musculoskeletal adverse reactions in patients treated with statins in primary and specialized care.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

An open-label, single arm, multicenter extension study to evaluate long-term safety and tolerability of inclisiran in participants with heterozygous or homozygous familial hypercholesterolemia who have completed the adolescent ORION-16 or ORION-13 studies (VICTORION-PEDS-OLE)

Germany, Spain, Hungary, Norway, Netherlands, Poland +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Effect of AZD0780 on Low Density Lipoprotein Cholesterol in Patients With Heterozygous Familial Hypercholesterolaemia

Slovakia, Bulgaria, Spain, Finland, Sweden, France +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hypercholesterolaemia trials by city

Hypercholesterolaemia in Toronto Hypercholesterolaemia in Vancouver Hypercholesterolaemia in Montreal Hypercholesterolaemia in Calgary Hypercholesterolaemia in Edmonton Hypercholesterolaemia in Ottawa Hypercholesterolaemia in Winnipeg Hypercholesterolaemia in Quebec City Hypercholesterolaemia in Hamilton Hypercholesterolaemia in Kitchener Hypercholesterolaemia in London Hypercholesterolaemia in Halifax Hypercholesterolaemia in New York Hypercholesterolaemia in Los Angeles Hypercholesterolaemia in Chicago Hypercholesterolaemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease